To investigate the role of SAMHD1 in MASLD, we evaluated its expression in liver samples from MASLD patients and non-MASLD controls, with baseline characteristics summarized in Supplementary Table S1. Here, SAMHD1 is linked to metabolic dysfunction-associated steatotic liver disease.